Form 4: SeaStar Medical Director Reports Share Acquisitions and RSU Grants Post-Reverse Split

Sentiment:

Insider Transaction Report


SeaStar Medical Holding Corp. Director Kenneth Van Heel disclosed the vesting of 4,000 restricted stock units and the grant of an additional 4,000 restricted stock units, with all share amounts adjusted for a recent 1-for-25 reverse stock split.

Summary

  • Kenneth Van Heel, a Director of SeaStar Medical Holding Corp. (ICU), reported changes in his beneficial ownership.
  • On June 4, 2025, 4,000 restricted stock units (RSUs) vested and converted into common stock. These RSUs were originally granted on November 13, 2024.
  • On July 10, 2025, Mr. Van Heel was granted an additional 4,000 restricted stock units, which are scheduled to vest in full on July 3, 2026.
  • All reported share amounts reflect adjustments made due to a 1-for-25 reverse stock split of the Issuer's common stock, which became effective on June 7, 2024.
  • Following these transactions, Mr. Van Heel beneficially owns 14,400 shares of SeaStar Medical Holding Corp. common stock.

Sentiment

Score: 5

Explanation: Neutral. The document is a standard Form 4 filing disclosing insider transactions. While the RSU grants are positive for director alignment, the mention of a recent reverse stock split could be perceived negatively, balancing the overall sentiment.

Positives

  • Grant of new restricted stock units (4,000 shares) to a director aligns management's interests with shareholders and serves as an incentive for future performance.
  • Vesting of previously granted restricted stock units (4,000 shares) indicates the fulfillment of prior compensation agreements.

Negatives

  • The disclosure mentions a 1-for-25 reverse stock split effective June 7, 2024, which often indicates a company's stock price has fallen significantly, potentially below exchange minimums, and is generally viewed negatively by investors.

Risks

  • The reverse stock split could indicate underlying financial or operational challenges that led to a low share price, potentially impacting future stock performance.

Future Outlook

Kenneth Van Heel was granted 4,000 new restricted stock units on July 10, 2025, which are scheduled to vest in full on July 3, 2026, indicating future compensation and retention.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions and does not provide broader industry context or trends. The reverse stock split, while company-specific, is a common action taken by companies with low share prices, often to maintain listing requirements.

Stakeholder Impact

  • Shareholders: The reverse stock split reduces the number of outstanding shares, potentially increasing the per-share price, but does not change the total value of holdings. The RSU grants dilute existing shareholders slightly upon vesting but align director incentives.

Next Steps

  • The newly granted 4,000 restricted stock units are expected to vest in full on July 3, 2026.

Key Dates

DateDescription
2024-06-07Effective date of the 1-for-25 reverse stock split of SeaStar Medical Holding Corp.'s common stock.
2024-11-13Date when 4,000 restricted stock units (RSUs) were previously granted to Kenneth Van Heel.
2025-06-04Date when 4,000 restricted stock units (RSUs) vested and converted into common stock for Kenneth Van Heel.
2025-07-10Date when Kenneth Van Heel was granted an additional 4,000 restricted stock units (RSUs).
2026-07-03Date when the newly granted 4,000 restricted stock units (RSUs) are scheduled to vest in full.

Recommendation

hold

Keywords

SeaStar Medical Holding Corp, ICU, SEC Form 4, Beneficial Ownership, Restricted Stock Units, RSU, Stock Grant, Stock Vesting, Reverse Stock Split, Insider Trading, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.